Gene · 2280
Papers1,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating intracellular nanovesicles into integrin trafficking pathways and beyond. | Cell Mol Life Sci | 2022 | 35657500 | PubTator, text mining | PubMed |
| A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19. | Sci Adv | 2022 | 35648852 | PubTator, text mining | PubMed |
| A spider silk-derived solubility domain inhibits nuclear and cytosolic protein aggregation in human cells. | Commun Biol | 2022 | 35618760 | PubTator, text mining | PubMed |
| Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit In Vivo Therapeutic Efficacy against Cryptococcus. | mBio | 2022 | 35604094 | PubTator, text mining | PubMed |
| Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia. | PLoS One | 2022 | 35587487 | PubTator, text mining | PubMed |
| Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant. | Thorax | 2022 | 35580897 | PubTator, text mining | PubMed |
| Identification and Validation of Autophagy-Related Genes in Diabetic Retinopathy. | Front Endocrinol (Lausanne) | 2022 | 35574010 | PubTator, text mining | PubMed |
| Physosmotic Induction of Chondrogenic Maturation Is TGF-β Dependent and Enhanced by Calcineurin Inhibitor FK506. | Int J Mol Sci | 2022 | 35563498 | PubTator, text mining | PubMed |
| Recent progress in drug development for fibrodysplasia ossificans progressiva. | Mol Cell Biochem | 2022 | 35536530 | PubTator, text mining | PubMed |
| Novel brown adipose tissue candidate genes predicted by the human gene connectome. | Sci Rep | 2022 | 35534514 | PubTator, text mining | PubMed |
| Regulation of A-to-I RNA editing and stop codon recoding to control selenoprotein expression during skeletal myogenesis. | Nat Commun | 2022 | 35523818 | PubTator, text mining | PubMed |
| Role of oxidation of excitation-contraction coupling machinery in age-dependent loss of muscle function in Caenorhabditis elegans. | Elife | 2022 | 35506650 | PubTator, text mining | PubMed |
| Comparative proteomics identify HSP90A, STIP1 and TAGLN-2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis. | Exp Ther Med | 2022 | 35495589 | PubTator, text mining | PubMed |
| Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by connectivity map-based analysis and in vitro studies. | BMC Complement Med Ther | 2022 | 35459166 | PubTator, text mining | PubMed |
| CD38-Cyclic ADP-Ribose Signal System in Physiology, Biochemistry, and Pathophysiology. | Int J Mol Sci | 2022 | 35457121 | PubTator, text mining | PubMed |
| FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis. | Cells | 2022 | 35456020 | PubTator, text mining | PubMed |
| Inflammation and Oxidative Stress as Common Mechanisms of Pulmonary, Autonomic and Musculoskeletal Dysfunction after Spinal Cord Injury. | Biology (Basel) | 2022 | 35453749 | PubTator, text mining | PubMed |
| Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis. | Biomedicines | 2022 | 35453576 | PubTator, text mining | PubMed |
| Tumor suppressor BAP1 nuclear import is governed by transportin-1. | J Cell Biol | 2022 | 35446349 | PubTator, text mining | PubMed |
| Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms. | Nat Commun | 2022 | 35440107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2280/papers?page=17